Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China
· Delayed Price · Currency is CNY 6.27
+0.07 (1.13%)
At close: Mar 10, 2026
Beijing SL Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,441 | 7,674 | 10,469 | 8,445 | 11,106 | 10,376 | Upgrade
|
| Market Cap Growth | -11.57% | -26.69% | 23.97% | -23.96% | 7.03% | -23.19% | Upgrade
|
| Enterprise Value | 5,496 | 6,762 | 9,607 | 7,404 | 10,195 | 9,699 | Upgrade
|
| Last Close Price | 6.27 | 7.45 | 9.96 | 7.95 | 10.35 | 9.57 | Upgrade
|
| PE Ratio | 79.25 | - | 25.12 | 36.03 | 26.07 | 28.45 | Upgrade
|
| Forward PE | - | 12.35 | 12.35 | 12.35 | 12.35 | 12.35 | Upgrade
|
| PS Ratio | 11.13 | 11.62 | 10.28 | 8.04 | 9.14 | 9.32 | Upgrade
|
| PB Ratio | 1.13 | 1.38 | 1.80 | 1.54 | 2.09 | 2.08 | Upgrade
|
| P/TBV Ratio | 1.29 | 1.57 | 2.05 | 1.71 | 2.30 | 2.28 | Upgrade
|
| P/FCF Ratio | - | - | 43.29 | 37.31 | 48.77 | 64.90 | Upgrade
|
| P/OCF Ratio | 70.15 | 34.03 | 22.75 | 21.66 | 23.90 | 24.95 | Upgrade
|
| PEG Ratio | - | 1.77 | 1.77 | 1.77 | 1.77 | 1.77 | Upgrade
|
| EV/Sales Ratio | 9.50 | 10.24 | 9.43 | 7.05 | 8.39 | 8.72 | Upgrade
|
| EV/EBITDA Ratio | 39.43 | 37.44 | 26.28 | 28.79 | 32.68 | 40.51 | Upgrade
|
| EV/EBIT Ratio | - | 244.58 | 43.65 | 51.54 | 48.02 | 64.68 | Upgrade
|
| EV/FCF Ratio | -19.24 | - | 39.72 | 32.71 | 44.77 | 60.66 | Upgrade
|
| Debt / Equity Ratio | - | - | - | - | 0 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.01 | 0.02 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.01 | 0.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.17 | -0.35 | -0.37 | -0.26 | -0.31 | -0.29 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.84 | -10.98 | -5.84 | -5.65 | -5.24 | -6.00 | Upgrade
|
| Net Debt / FCF Ratio | 3.34 | 16.26 | -8.82 | -6.42 | -7.17 | -8.99 | Upgrade
|
| Asset Turnover | 0.10 | 0.11 | 0.17 | 0.18 | 0.22 | 0.21 | Upgrade
|
| Inventory Turnover | 0.69 | 1.09 | 1.34 | 1.20 | 1.55 | 1.52 | Upgrade
|
| Quick Ratio | 5.07 | 7.27 | 6.35 | 6.02 | 6.20 | 6.07 | Upgrade
|
| Current Ratio | 12.37 | 8.60 | 7.07 | 6.92 | 7.07 | 7.01 | Upgrade
|
| Return on Equity (ROE) | 1.47% | -1.32% | 7.35% | 4.23% | 8.17% | 7.37% | Upgrade
|
| Return on Assets (ROA) | -0.20% | 0.28% | 2.26% | 1.54% | 2.38% | 1.76% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.45% | 0.76% | 5.10% | 3.28% | 5.40% | 4.07% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.30% | 0.50% | 3.70% | 2.60% | 3.90% | 3.00% | Upgrade
|
| Earnings Yield | 1.30% | -0.97% | 3.98% | 2.78% | 3.84% | 3.52% | Upgrade
|
| FCF Yield | -4.44% | -1.59% | 2.31% | 2.68% | 2.05% | 1.54% | Upgrade
|
| Dividend Yield | 0.32% | 0.27% | 1.51% | 1.26% | 0.97% | 1.04% | Upgrade
|
| Payout Ratio | 25.28% | - | 24.65% | 43.83% | 24.17% | 56.44% | Upgrade
|
| Buyback Yield / Dilution | -4.23% | -4.11% | 0.28% | 1.90% | -2.55% | 2.19% | Upgrade
|
| Total Shareholder Return | -3.91% | -3.84% | 1.78% | 3.16% | -1.58% | 3.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.